Essex Investment Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-84,690
| Closed | -$610K | – | 403 |
|
|
2018
Q1 | $610K | Sell |
84,690
-23,038
| -21% | -$166K | 0.08% | 254 |
|
|
2017
Q4 | $878K | Buy |
107,728
+28,970
| +37% | +$236K | 0.12% | 224 |
|
|
2017
Q3 | $1.14M | Buy |
78,758
+32,229
| +69% | +$467K | 0.16% | 196 |
|
|
2017
Q2 | $563K | Buy |
46,529
+17,510
| +60% | +$212K | 0.08% | 249 |
|
|
2017
Q1 | $373K | Buy |
+29,019
| New | +$373K | 0.06% | 286 |
|